Marshall Wace’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$382M Sell
1,410,334
-293,804
-17% -$87.5M 0.38% 28
2025
Q4
$563M Buy
1,704,138
+1,484,817
+677% +$503M 0.51% 22
2025
Q3
$75.7M Sell
219,321
-934,488
-81% -$283M 0.08% 224
2025
Q2
$360M Buy
1,153,809
+222,643
+24% +$85.1M 0.41% 31
2025
Q1
$488M Sell
931,166
-1,023,067
-52% -$523M 0.62% 17
2024
Q4
$989M Buy
1,954,233
+1,645,530
+533% +$935M 1.19% 7
2024
Q3
$180M Sell
308,703
-52,156
-14% -$29.5M 0.22% 75
2024
Q2
$184M Buy
360,859
+264,801
+276% +$130M 0.25% 65
2024
Q1
$47.5M Sell
96,058
-152,100
-61% -$77.3M 0.07% 269
2023
Q4
$131M Sell
248,158
-14,129
-5% -$7.54M 0.22% 86
2023
Q3
$132M Sell
262,287
-108,729
-29% -$53.5M 0.27% 69
2023
Q2
$178M Sell
371,016
-91,991
-20% -$45M 0.35% 49
2023
Q1
$219M Buy
463,007
+457,936
+9,030% +$221M 0.46% 34
2022
Q4
$2.69M Sell
5,071
-127,261
-96% -$67.4M 0.01% 1562
2022
Q3
$66.8M Sell
132,332
-877,539
-87% -$461M 0.15% 138
2022
Q2
$519M Sell
1,009,871
-334,311
-25% -$168M 1.07% 5
2022
Q1
$685M Buy
1,344,182
+482,384
+56% +$233M 1.3% 4
2021
Q4
$433M Buy
861,798
+829,614
+2,578% +$376M 0.8% 11
2021
Q3
$12.6M Buy
32,184
+17,797
+124% +$7.37M 0.05% 431
2021
Q2
$5.76M Sell
14,387
-17,348
-55% -$6.92M 0.03% 768
2021
Q1
$11.8M Sell
31,735
-27,518
-46% -$9.54M 0.05% 375
2020
Q4
$20.8M Buy
59,253
+26,911
+83% +$9.02M 0.11% 185
2020
Q3
$10.1M Buy
32,342
+14,477
+81% +$4.45M 0.06% 299
2020
Q2
$5.27M Sell
17,865
-198,441
-92% -$56.9M 0.04% 450
2020
Q1
$53.9M Buy
+216,306
New +$59.5M 0.54% 33
2019
Q4
Sell
-38,600
Closed -$8.39M 2075
2019
Q3
$8.39M Buy
+38,600
New +$9.31M 0.07% 345
2019
Q2
Sell
-45,151
Closed -$11.2M 1858
2019
Q1
$11.2M Sell
45,151
-5,326
-11% -$1.36M 0.1% 234
2018
Q4
$12.6M Sell
50,477
-29,664
-37% -$7.84M 0.13% 190
2018
Q3
$21.3M Buy
80,141
+65,615
+452% +$17.1M 0.18% 156
2018
Q2
$3.56M Sell
14,526
-84,090
-85% -$20.2M 0.05% 350
2018
Q1
$21.1M Buy
98,616
+61,606
+166% +$14.1M 0.87% 27
2017
Q4
$8.16M Buy
37,010
+26,670
+258% +$5.65M 0.34% 64
2017
Q3
$2.03M Sell
10,340
-3,595
-26% -$695K 0.09% 160
2017
Q2
$2.58M Buy
13,935
+11,361
+441% +$1.99M 0.11% 126
2017
Q1
$422K Sell
2,574
-719,230
-100% -$118M 0.02% 256
2016
Q4
$116M Buy
721,804
+712,343
+7,529% +$106M 0.76% 16
2016
Q3
$1.32M Sell
9,461
-708,759
-99% -$99.3M 0.01% 677
2016
Q2
$101M Buy
718,220
+285,242
+66% +$38M 0.85% 18
2016
Q1
$55.8M Sell
432,978
-53,586
-11% -$6.34M 0.54% 46
2015
Q4
$57.2M Buy
486,564
+336,405
+224% +$39.3M 0.54% 41
2015
Q3
$17.4M Buy
+150,159
New +$18M 0.21% 119
2014
Q3
Sell
-16,569
Closed -$1.35M 1051
2014
Q2
$1.35M Buy
+16,569
New +$1.3M 0.02% 457

Other funds holding UNH

Marshall Wace's UNH Position: Q1 2026 in Review

Marshall Wace reduced its UnitedHealth (UNH) stake by 17% in Q1 2026, selling an estimated $87.5M and leaving 1,410,334 shares worth $382M. The position accounts for 0.38% of the portfolio, ranked #28.

Marshall Wace first reported a position in UNH in Q2 2014 and has held it in 42 quarters since. The position peaked at $989M in Q4 2024. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Marshall Wace held 1,410,334 shares of UnitedHealth worth $382M as of Q1 2026.
  • Marshall Wace sold 293,804 UnitedHealth shares in Q1 2026, an estimated $87.5M.
  • UnitedHealth made up 0.38% of Marshall Wace's portfolio in Q1 2026, its #28 holding.
  • Marshall Wace first reported a position in UnitedHealth in Q2 2014 and has held it in 42 quarters since.
  • Marshall Wace's UnitedHealth position peaked at $989M in Q4 2024.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.